Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complaints with Prefilled Pen B in Type 2 Diabetes on Twice-Daily Insulin
2005-002115-24Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Primary endpoint: Complaints related to Prefilled Pen B use. Started Jul 2005; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002115-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002115-24.